Gastroenterology

Andrew Joseph Muir, MD

Professor of Medicine
Chief, Division of Gastroenterology in the Department of Medicine
Member in the Duke Clinical Research Institute
Campus mail 03137B Hosp South, Durham, NC 27710
Phone (919) 684-2052
Email address andrew.muir@duke.edu
  • Hepatitis C 
  • Primary sclerosing cholangitis
  • Cirrhosis
  • Liver Transplantation
  • Clinical Trials
  • Healthcare disparities in liver disease 
  • Outcomes Research

Education and Training

  • Fellow in Gastroenterology, Medicine, Duke University, 1998 - 2000
  • Chief Medical Resident, Medicine, Duke University, 1997 - 1998
  • Fellow in Gastroenterology, Medicine, Duke University, 1996 - 1997
  • Medical Resident, Medicine, Duke University, 1993 - 1996
  • M.H.S., Duke University, 2001
  • M.D., Duke University, 1993

Grants

Publications

Kappus, Matthew R., Kara Wegermann, Erol Bozdogan, Yuval A. Patel, Gemini Janas, Erin Shropshire, Alice Parish, Donna Niedzwiecki, Andrew J. Muir, and Mustafa Bashir. “Use of Skeletal Muscle Index as a Predictor of Wait-List Mortality in Patients With End-Stage Liver Disease.” In Liver Transpl, 26:1090–99, 2020. https://doi.org/10.1002/lt.25802.

PMID
32433802
Full Text

Muir, Andrew J. “What Clues Can We Use From Primary Sclerosing Cholangitis With Inflammatory Bowel Disease Phenotypes?” Clin Gastroenterol Hepatol 18, no. 10 (September 2020): 2173–75. https://doi.org/10.1016/j.cgh.2020.03.053.

PMID
32240834
Full Text

Gindin, Yevgeniy, Chuhan Chung, Zhaoshi Jiang, Jing Zhu Zhou, Jun Xu, Andrew Billin, Robert P. Myers, et al. “A Fibrosis-Independent Hepatic Transcriptomic Signature Identifies Novel Drivers of Disease Progression in Primary Sclerosing Cholangitis.” Hepatology (Baltimore, Md.), August 3, 2020. https://doi.org/10.1002/hep.31488.

PMID
32745270
Full Text

Trivedi, Palak J., Andrew J. Muir, Cynthia Levy, Christopher L. Bowlus, Michael Manns, Xiaomin Lu, Gerald Crans, et al. “Inter- and Intra-individual Variation, and Limited Prognostic Utility, of Serum Alkaline Phosphatase in a Trial of Patients With Primary Sclerosing Cholangitis.” Clin Gastroenterol Hepatol, July 22, 2020. https://doi.org/10.1016/j.cgh.2020.07.032.

PMID
32707342
Full Text

Zuckerman, Eli, Julio A. Gutierrez, Douglas E. Dylla, Victor de Ledinghen, Andrew J. Muir, Michael Gschwantler, Massimo Puoti, et al. “Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection.” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, July 2020. https://doi.org/10.1016/j.cgh.2020.06.044.

PMID
32621971
Full Text

Proeschold-Bell, Rae Jean, Donna M. Evon, Jia Yao, Donna Niedzwiecki, Christina Makarushka, Kelly A. Keefe, Ashwin A. Patkar, et al. “A Randomized Controlled Trial of an Integrated Alcohol Reduction Intervention in Patients With Hepatitis C Infection.” Hepatology 71, no. 6 (June 2020): 1894–1909. https://doi.org/10.1002/hep.31058.

PMID
31803945
Full Text

Bashir, Mustafa R., and Andrew J. Muir. “Great Expectations: Can Magnetic Resonance Elastography Accelerate Progress in Primary Sclerosing Cholangitis Research?” Clin Gastroenterol Hepatol 18, no. 7 (June 2020): 1436–38. https://doi.org/10.1016/j.cgh.2019.12.013.

PMID
31863860
Full Text

Henson, Jacqueline B., Julius M. Wilder, Matthew R. Kappus, Andrew S. Barbas, Cynthia A. Moylan, Donna Niedzwiecki, Andrew J. Muir, Carl L. Berg, and Yuval A. Patel. “Transplant Outcomes in Older Patients With Nonalcoholic Steatohepatitis Compared to Alcohol-related Liver Disease and Hepatitis C.” Transplantation 104, no. 6 (June 2020): e164–73. https://doi.org/10.1097/TP.0000000000003219.

PMID
32150036
Full Text

Sulkowski, Mark, Annie F. Luetkemeyer, David L. Wyles, Claudia Martorell, Andrew Muir, Ilan Weisberg, Stuart C. Gordon, Richard McLain, and Gregory Huhn. “Impact of a digital medicine programme on hepatitis C treatment adherence and efficacy in adults at high risk for non-adherence.” Aliment Pharmacol Ther 51, no. 12 (June 2020): 1384–96. https://doi.org/10.1111/apt.15707.

PMID
32352586
Full Text

Koutlas, Nicholas, Brian C. Allen, James H. Helzberg, Donna Niedzwiecki, Alice Parish, Mustafa R. Bashir, and Andrew J. Muir. “VALIDATION OF MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY RISK PREDICTION SCORES TO PREDICT CLINICAL EVENTS IN PRIMARY SCLEROSING CHOLANGITIS.” In Gastroenterology, 158:S1372–73, 2020.

Scholars@Duke

Pages